GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syngene International Ltd (BOM:539268) » Definitions » Price-to-Operating-Cash-Flow

Syngene International (BOM:539268) Price-to-Operating-Cash-Flow : (As of May. 01, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Syngene International Price-to-Operating-Cash-Flow?

As of today (2024-05-01), Syngene International's share price is ₹688.95. Syngene International's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.00. Hence, Syngene International's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Syngene International's Price-to-Operating-Cash-Flow or its related term are showing as below:

BOM:539268' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0   Med: 0   Max: 44.58
Current: 26.89

During the past 13 years, Syngene International's highest Price-to-Operating-Cash-Flow Ratio was 44.58. The lowest was 0.00. And the median was 0.00.

BOM:539268's Price-to-Operating-Cash-Flow is ranked worse than
51.9% of 289 companies
in the Biotechnology industry
Industry Median: 26.12 vs BOM:539268: 26.89

Syngene International's Cash Flow from Operations per share for the three months ended in Mar. 2024 was ₹0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.00.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Syngene International was 27.00% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 14.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 8.30% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 24.90% per year.

During the past 13 years, Syngene International's highest 3-Year average Operating Cash Flow per Share Growth Rate was 188.30% per year. The lowest was -49.30% per year. And the median was 14.90% per year.


Syngene International Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Syngene International's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syngene International Price-to-Operating-Cash-Flow Chart

Syngene International Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.20 31.05 41.42 29.13 27.06

Syngene International Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.13 - - - 27.06

Competitive Comparison of Syngene International's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Syngene International's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syngene International's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syngene International's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Syngene International's Price-to-Operating-Cash-Flow falls into.



Syngene International Price-to-Operating-Cash-Flow Calculation

Syngene International's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=688.95/0
=

Syngene International's Share Price of today is ₹688.95.
Syngene International's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Syngene International Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Syngene International's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Syngene International (BOM:539268) Business Description

Traded in Other Exchanges
Address
Jigani Link Road, Biocon SEZ, Biocon Park, Plot No. 2 and 3, IV Phase, Bommasandra Industrial Area, Bangalore, KA, IND, 560 099
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the US. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.

Syngene International (BOM:539268) Headlines

No Headlines